Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 13;59(4):757.
doi: 10.3390/medicina59040757.

Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease

Narantsatsral Daramjav  1 , Junko Takagi  1 , Hideyuki Iwayama  2 , Kaori Uchino  3 , Daisuke Inukai  4 , Kazuo Otake  1 , Tetsuya Ogawa  4 , Akiyoshi Takami  3
Affiliations
Review

Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease

Narantsatsral Daramjav et al. Medicina (Kaunas). .

Abstract

In 15-20% of cases, Graves' disease (GD) shifts to Hashimoto's thyroiditis (HT), while the shift from HT to GD is rare. We present a case of a patient in whom HT shifted to GD, along with a literature review. A 50-year-old woman with myxedema was diagnosed with Hashimoto's disease due to hypothyroidism and the presence of antibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TgAb); she also had thyroid stimulating antibodies (TSAb) without any signs of GD. Although thyroid hormone replacement therapy improved her thyroid function, 2 months later, hyperthyroidism appeared and did not improve after discontinuation of the replacement therapy. The patient was diagnosed with GD, which improved with antithyroid agent administration. To date, only 50 cases regarding conversion from HT to GD have been reported. The median age is 44 years (range, 23-82 years), and the median time of conversion is 7 years (range, 0.1-27 years). The male-to-female ratio of HT conversion to GD is 1:9, closer to that of regular GD (1:10) than that of general HT (1:18). All patients received thyroid hormone replacement therapy for hypothyroidism due to HT. Continuous evaluation of TSAb levels is recommended in HT, particularly in cases of TSAb-positive and those under replacement, since it may help predict conversion to GD. Evaluating the clinical characteristics of patients with HT preceding GD is crucial to ensure appropriate treatment and reduce the risk of adverse events.

Keywords: Graves’ disease; Hashimoto thyroiditis; autoimmune disease; thyroid antibodies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Thyroid US at the onset of GD. The right lobe in the sagittal view shows normal echogenicity and mild hypervascularity. The size of the right lobe was 1.18 × 1.31 × 4.32 cm (volume 3.5 cm3) and within normal range.
Figure 2
Figure 2
The image of thyroid gland in 99mTc scan. No remarkable accumulation of 99mTc was observed focally or in the whole thyroid gland. The uptake ratio was 0.76% at 30 min, which was within normal range.
See this image and copyright information in PMC

References

    1. Effraimidis G., Wiersinga W.M. Mechanisms in endocrinology: Autoimmune thyroid disease: Old and new players. Eur. J. Endocrinol. 2014;170:R241–R252. doi: 10.1530/EJE-14-0047. - DOI - PubMed
    1. Antonelli A., Ferrari S.M., Ragusa F., Elia G., Paparo S.R., Ruffilli I., Patrizio A., Giusti C., Gonnella D., Cristaudo A., et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best Pract. Res. Clin. Endocrinol. Metab. 2020;34:101387. doi: 10.1016/j.beem.2020.101387. - DOI - PubMed
    1. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto’s thyroiditis: A comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocr. J. 2003;50:113–116. doi: 10.1507/endocrj.50.113. - DOI - PubMed
    1. Kamath C., Young S., Kabelis K., Sanders J., Adlan M.A., Furmaniak J., Rees Smith B., Premawardhana L.D. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto’s who developed Graves’ disease and pretibial myxoedema. Clin. Endocrinol. 2012;77:465–470. doi: 10.1111/j.1365-2265.2012.04397.x. - DOI - PubMed
    1. Kraiem Z., Baron E., Kahana L., Sadeh O., Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyper-thyroidism and back to hypothyroidism. Clin. Endocrinol. 1992;36:211–214. doi: 10.1111/j.1365-2265.1992.tb00960.x. - DOI - PubMed